Kiniksa Pharmaceuticals International PLC (KNSA)
22.03
+0.55
(+2.56%)
USD |
NASDAQ |
Nov 05, 16:00
22.03
0.00 (0.00%)
After-Hours: 18:13
Kiniksa Pharmaceuticals International Market Cap: 1.591B for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.551B |
| November 01, 2024 | 1.623B |
| October 31, 2024 | 1.631B |
| October 30, 2024 | 1.661B |
| October 29, 2024 | 1.680B |
| October 28, 2024 | 1.992B |
| October 25, 2024 | 1.981B |
| October 24, 2024 | 1.942B |
| October 23, 2024 | 1.937B |
| October 22, 2024 | 1.933B |
| October 21, 2024 | 1.868B |
| October 18, 2024 | 1.895B |
| October 17, 2024 | 1.930B |
| October 16, 2024 | 1.899B |
| October 15, 2024 | 1.953B |
| October 14, 2024 | 1.922B |
| October 11, 2024 | 1.917B |
| October 10, 2024 | 1.839B |
| October 09, 2024 | 1.799B |
| October 08, 2024 | 1.766B |
| October 07, 2024 | 1.712B |
| October 04, 2024 | 1.766B |
| October 03, 2024 | 1.753B |
| October 02, 2024 | 1.770B |
| October 01, 2024 | 1.838B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.803B |
| September 27, 2024 | 1.781B |
| September 26, 2024 | 1.707B |
| September 25, 2024 | 1.717B |
| September 24, 2024 | 1.742B |
| September 23, 2024 | 1.754B |
| September 20, 2024 | 1.827B |
| September 19, 2024 | 1.870B |
| September 18, 2024 | 1.800B |
| September 17, 2024 | 1.809B |
| September 16, 2024 | 1.792B |
| September 13, 2024 | 1.800B |
| September 12, 2024 | 1.745B |
| September 11, 2024 | 1.734B |
| September 10, 2024 | 1.719B |
| September 09, 2024 | 1.713B |
| September 06, 2024 | 1.776B |
| September 05, 2024 | 1.807B |
| September 04, 2024 | 1.834B |
| September 03, 2024 | 1.853B |
| August 30, 2024 | 1.905B |
| August 29, 2024 | 1.906B |
| August 28, 2024 | 1.879B |
| August 27, 2024 | 1.928B |
| August 26, 2024 | 1.963B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
353.98M
Minimum
Nov 14 2019
1.992B
Maximum
Oct 28 2024
1.077B
Average
1.051B
Median
Jun 08 2023
Market Cap Benchmarks
| OPKO Health Inc | 1.010B |
| Ligand Pharmaceuticals Inc | 2.030B |
| Organon & Co | 4.238B |
| NovaBay Pharmaceuticals Inc | 3.762M |
| Palatin Technologies Inc | 22.87M |
Market Cap Related Metrics
| PS Ratio | 4.175 |
| PEG Ratio | -5.770 |
| Price to Book Value | 3.640 |
| Price to Free Cash Flow | 144.43 |
| Price | 22.03 |
| Earnings Yield | -0.64% |
| PEGY Ratio | -5.770 |